Eyevensys Named to French Tech 120 Program
Eyevensys Named to French Tech 120 Program https://www.eyevensys.com/wp-content/uploads/2018/08/thisisengineering-raeng-qI7USKbZY_A-unsplash.jpg 1920 1281 Eyevensys https://www.eyevensys.com/wp-content/uploads/2018/08/thisisengineering-raeng-qI7USKbZY_A-unsplash.jpgParis, France, and Cambridge, Mass., United States, October 05, 2020 – Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies…